Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis
Life Sciences · 2026-12 · 406 · 124751
DOI: 10.1016/j.lfs.2026.124751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-12. Verfasst von Sourav Kundu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Changsari, Assam, 781101, In…. Hauptthemen laut MEDLINE: Oxidative Stress, Diabetic Cardiomyopathies, Ferroptosis, Benzopyrans. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
AIMS: Diabetes mellitus-associated cardiac dysfunction arises from metabolic imbalance, oxidative stress, inflammation, maladaptive remodeling, and impaired cardiac performance. Bergenin (BER), a naturally occurring small molecule with antioxidant, anti-inflammatory, and metabolic regulatory properties, has shown therapeutic potential; however, its role in diabetic cardiomyopathy (DCM) remains unclear. This study investigated the cardioprotective effects of BER in DCM, with particular emphasis on oxidative stress, the Hippo-Yes-associated protein (YAP), and ferroptosis signaling axis. MATERIALS AND METHODS: DCM was induced in rats using a high-fat diet combined with low-dose streptozotocin (STZ). Diabetic rats received BER (25 or 50 mg/kg/day) or empagliflozin (10 mg/kg/day). Cardiac function was evaluated by echocardiography, followed by histopathological and molecular analyses. To further investigate the underlying mechanisms, H9c2 cardiomyoblasts exposed to high glucose were used for in vitro assessment of oxidative stress, Hippo-YAP signaling, and ferroptosis-related markers. KEY FINDINGS: In vivo, BER treatment significantly improved cardiac function, attenuated histopathological injury, and reduced cardiomyocyte hypertrophy and fibrosis in diabetic rats. Consistent with these findings, in vitro, BER reduced reactive oxygen species generation, restored mitochondrial integrity, and prevented high glucose-induced injury in H9c2 cells. Mechanistically, BER modulated YAP signaling and suppressed ferroptosis-related changes. YAP silencing attenuated the protective effects of BER, supporting a critical role for YAP in mediating its anti-ferroptotic effects. SIGNIFICANCE: These findings demonstrate that BER exerts cardioprotective effects against diabetes-associated cardiac dysfunction and provide mechanistic evidence implicating the YAP-ferroptosis axis in this protection. Further studies are warranted to establish its translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Changsari, Assam, 781101, India.
- Department of Toxicology and Experimental Medicine, CSIR-Central Drug Research Institute (CDRI), Lucknow, Uttar Pradesh, 226031, India.
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Changsari, Assam, 781101, India. Electronic address: bidya.sahu@niperguwahati.ac.in.
Zitieren
APA
Kundu, S., Yadav, M., Mugale, M. N., & Sahu, B. D. (2026). Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis. Life Sciences, 406, 124751. https://doi.org/10.1016/j.lfs.2026.124751
Vancouver
Kundu S, Yadav M, Mugale MN, Sahu BD. Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis. Life Sciences. 2026;406:124751. doi:10.1016/j.lfs.2026.124751
BibTeX
@article{Kundu2026,
author = {Kundu, Sourav and Yadav, Manisha and Mugale, Madhav Nilakanth and Sahu, Bidya Dhar},
title = {Bergenin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and ferroptosis through modulation of the YAP signaling axis},
journal = {Life Sciences},
year = {2026},
volume = {406},
pages = {124751},
doi = {10.1016/j.lfs.2026.124751}
}
EUVIMED